16-4337362-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_032575.3(GLIS2):​c.1413C>G​(p.Ser471Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,592,968 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S471N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 1 hom. )

Consequence

GLIS2
NM_032575.3 missense

Scores

2
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.449

Publications

3 publications found
Variant links:
Genes affected
GLIS2 (HGNC:29450): (GLIS family zinc finger 2) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
PAM16 (HGNC:29679): (presequence translocase associated motor 16) This gene encodes a mitochondrial protein involved in granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. This protein also plays a role in the import of nuclear-encoded mitochondrial proteins into the mitochondrial matrix and may be important in reactive oxygen species (ROS) homeostasis. Mutations in this gene cause Megarbane-Dagher-Melike type spondylometaphyseal dysplasia, an early lethal skeletal dysplasia characterized by short stature, developmental delay and other skeletal abnormalities. [provided by RefSeq, May 2017]
PAM16 Gene-Disease associations (from GenCC):
  • autosomal recessive spondylometaphyseal dysplasia, Megarbane type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026683211).
BP6
Variant 16-4337362-C-G is Benign according to our data. Variant chr16-4337362-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 319223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS2NM_032575.3 linkc.1413C>G p.Ser471Arg missense_variant Exon 7 of 7 ENST00000433375.2 NP_115964.2
GLIS2NM_001318918.2 linkc.1413C>G p.Ser471Arg missense_variant Exon 8 of 8 NP_001305847.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS2ENST00000433375.2 linkc.1413C>G p.Ser471Arg missense_variant Exon 7 of 7 1 NM_032575.3 ENSP00000395547.1
GLIS2ENST00000262366.7 linkc.1413C>G p.Ser471Arg missense_variant Exon 8 of 8 2 ENSP00000262366.3
ENSG00000262712ENST00000574705.1 linkn.457G>C non_coding_transcript_exon_variant Exon 1 of 1 6
PAM16ENST00000577031.5 linkc.291+3558G>C intron_variant Intron 4 of 4 4 ENSP00000459113.1

Frequencies

GnomAD3 genomes
AF:
0.00107
AC:
163
AN:
152192
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00379
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000207
AC:
43
AN:
207892
AF XY:
0.000149
show subpopulations
Gnomad AFR exome
AF:
0.00338
Gnomad AMR exome
AF:
0.0000934
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000101
AC:
145
AN:
1440658
Hom.:
1
Cov.:
34
AF XY:
0.0000993
AC XY:
71
AN XY:
715158
show subpopulations
African (AFR)
AF:
0.00375
AC:
124
AN:
33028
American (AMR)
AF:
0.000140
AC:
6
AN:
42952
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25708
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83074
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48512
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5746
European-Non Finnish (NFE)
AF:
0.00000362
AC:
4
AN:
1103496
Other (OTH)
AF:
0.000185
AC:
11
AN:
59550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00107
AC:
163
AN:
152310
Hom.:
1
Cov.:
33
AF XY:
0.00111
AC XY:
83
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00378
AC:
157
AN:
41566
American (AMR)
AF:
0.000327
AC:
5
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68012
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000179
Hom.:
0
Bravo
AF:
0.00115
ESP6500AA
AF:
0.00186
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000268
AC:
32

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephronophthisis Benign:1
Nov 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nephronophthisis 7 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

GLIS2-related disorder Benign:1
Feb 13, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.0
.;.
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.0027
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
-0.45
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.67
N;N
REVEL
Benign
0.068
Sift
Uncertain
0.0030
D;D
Sift4G
Benign
0.12
T;T
Vest4
0.11
ClinPred
0.027
T
GERP RS
2.5
Varity_R
0.14
gMVP
0.44
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201182025; hg19: chr16-4387363; API